The insulin level and blood sugar level are not the same: A “sugar diet” alone isn’t expedient because humans don’t change the insulin through their diets, but rather the blood sugar level. A exception to this are diabetics.
So how exactly is the reduction of the blood sugar level used in the treat of cancer? A combination made from syrosingopin and an antihypertonic with metformin is used to reduce the blood sugar level, and has been shown in diverse studies to be effective against cancer. The effects of metformin have long been known to reduce blood sugar, but alone it cannot be used to be clinically useful, so it is combined with syrosingopin in integrative cancer treatments to help you win your fight against cancer.
Feel free to contact us!
Prof. Drevs and his team stay up to date on the latest discoveries in cancer research and use this to supplement your individual diagnosis and therapeutic treatments. Prof. Drevs would be glad to give you a personal consultation about the benefits, possibilities, and risks of the latest cancer treatments. Please contact us for more information!
UNIFONTIS | Prof. Dr. med. Joachim Drevs
Specialist for internal medicine
Additional qualification in hematology / private oncology doctor
Fax: +49 (0)5305-1317
Central contact number:
© Copyright UNIFONTIS. Alle Rechte vorbehalten.